Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.
Pediatric Inflammatory Diseases. Part II: Acute Post-Infectious Immune Disorders.
Evidence of aquaporin involvement in human central pontine myelinolysis.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.
PML after natalizumab discontinuation: Few and true?
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review.
Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research: Consensus Recommendation from the International MS Falls Prevention Research Network.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
[MRI and CSF features in neuromyelitis optica].
[MR imaging of multiple sclerosis].
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex.
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Twenty years of experience on stem cell transplantation in iran.
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.
Pages
« first
‹ previous
…
598
599
600
601
602
603
604
605
606
…
next ›
last »